Thus, various interventions inhibiting AT1R or activating AT2R and Mas receptors as well as affecting different signal transduction pathways can be seen to produce beneficial effects in reducing the oxidative stress, inflammation, and intracellular Ca2+- overload for preventing the Ang II-induced cardiac hypertrophy. This evidence concerns the gene AGTR1 and cardiac hypertrophy.